
样式: 排序: IF: - GO 导出 标记为已读
-
Genetic diseases underlying a spectrum of fetal effusions. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-08 Natalie B Gulrajani,Billie R Lianoglou,Katie Tick,Nuriye N Sahin-Hodoglugil,Ugur Hodoglugil,Patrick Devine,Jessica Van Ziffle,Mary E Norton,Teresa N Sparks
INTRODUCTION Non-immune hydrops fetalis (NIHF) is well understood to be heterogenous and the common endpoint of many genetic diseases. However, less is known about the prevalence and presenting features of genetic diseases that underlie other types of fetal effusions such as single effusions, leaving uncertainty in clinical practice about optimal approaches to testing and counseling for these pregnancies
-
Hypoxic-ischemic encephalopathy following intrapartum asphyxia: is it avoidable? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-08 Mikko Tarvonen,Riina Jernman,Vedran Stefanovic,Ville Tuppurainen,Riitta Karikoski,Leena Haataja,Sture Andersson
BACKGROUND The proportion of term hypoxic-ischemic encephalopathy arising during intrapartum fetal surveillance remains unclear. Moreover, recent Cochrane review and other studies emphasized the need for research on the impact of admission cardiotocography, and highlighted the necessity for a definition of 'avoidable perinatal brain injury'. OBJECTIVE To assess the impact of intrapartum asphyxia on
-
Association of Reproductive Access Restrictions and Out-of-State Abortion Care in Colorado, an Interrupted Time Series Analysis for 2018-2024. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-08 Kelly A DeBie,Kayleigh P Keller,Jennifer L Peel,Margaret J Gutilla,Andreas M Neophytou
OBJECTIVE Access to abortion has changed dramatically in the United States in recent years, both at the federal and state level. For nearly fifty years, the right to abortion was considered federally protected right under the Roe v. Wade (1973) recognition of privacy rights under the 14th Amendment. In September 2021, Texas passed SB8 which implemented a 6-week restriction on access to abortion. The
-
Predictors of Neonatal Survival in Pregnancies undergoing Serial Amnioinfusions for in utero Renal Failure. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-07 Braxton Forde,Stefanie Riddle,Foong-Yen Lim,David N McKinney,Kara Markham,Mallory Hoffman,Jose L Peiro,Mel Minges,Meredith Schuh,Donna J Claes,Mounira Habli
-
Lack of Inclusion of Pregnant Individuals in Industry-Funded Clinical Trials : problems raised in oncology and detour solutions. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-07 Estelle Heggarty,Hadia Moindjie,Paul Berveiller
-
Prenatal exposure to vaginal progesterone for the prevention of preterm birth is not associated with abnormal psychopathological and cognitive profiles in dichorionic twins at 6 to 9 years of age: a follow-up study of a randomized controlled trial. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-06 Alfredo Perales,Joan Aviño,Alba Diaz-Martinez,Agustin Conde-Agudelo,Roberto Romero,Luis Rojo,Vicente Serra
BACKGROUND Current evidence indicates that administration of vaginal progesterone to women with a twin gestation and a short cervix reduces the risk of preterm birth occurring at early gestational ages and of neonatal morbidity and mortality. However, the potential long-term effects of prenatal administration of vaginal progesterone for preventing preterm birth on the psychopathological and cognitive
-
Experimental evidence that cervical cerclage prevents ascending intra-amniotic infection. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-06 Samuel Parry
-
Frequency and timing of complications within the first postpartum year in the United States and Canada: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-05 Janny Xue Chen Ke,Katherine Bilan,Marianne Vidler,Mike Wong,Anthony Chau,Qian Zhang,Jeffrey N Bone,Andrea Enriquez,Ria Sandhu,Ronald B George,Rebecca A Baron,Ammar M Lakda,Justine Dol,Lindsay Blake,Brendan Carvalho,Ronald S Gibbs,Micaela Coombs,Sonia Sekhon,Ernest Tang,Pervez Sultan
OBJECTIVE Understanding the rates and timing of postpartum complications can facilitate timely screening and management to reduce preventable morbidity and mortality. The aim of this study was to summarize the frequency (prevalence or incidence) and timing of complications from hospital delivery to one year postpartum in the United States and Canada. DATA SOURCES PubMed MEDLINE, Web of Science, EBSCO
-
Prenatal diagnosis of subamniotic placental cysts. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-05 Nareenun Chansriniyom,Roberto Romero,Puntabut Warintaksa,Arun Meyyazhagan,Patama Promsonthi,Arunee Singhsnaeh,Piya Chaemsaithong
-
Association of placenta accreta spectrum and vasa previa. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-05 Yadira L Bribiesca Leon,Shinya Matsuzaki,Zaira N Chavez Jimenez,Fay F Pon,Emi J Komatsu,Jennifer A Yao,Rachel S Mandelbaum,Brian J Gordon,Joseph G Ouzounian,Koji Matsuo
-
Enhancing Reproductive Access: The Influence of Expanded Employer Fertility Benefits at a Single Academic Center from 2017-2021. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-05 Alexandra M Herweck,Miranda Lm Delawalla,Caroline Reed,Traci L Carson,Avni Ahuja,Paris Chey,Maeve McNamara,Khushi Gupta,Allison Bosch,Heather S Hipp,Jennifer F Kawwass
BACKGROUND Recognized by the World Health Organization as a disease, infertility carries emotional and financial burdens. With treatments like in vitro fertilization (IVF) costing approximately $12,400 (not including medications), many Americans may allocate a substantial portion of their annual income to a single assisted reproductive technology (ART) cycle. To mitigate this burden, a minority of
-
Reshaping the Landscape of Ovarian Cancer: Implications from the Surgery for Ovarian cancer FIGO 4 Study. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-04 Halil Göksel Güzel,Onur Yazdan Balçık,Yusuf İlhan
-
Closing Gaps in Perinatal Mental Health Care in the United States. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-03 Jiage Qian,Carrie Wolfson,Andreea A Creanga
-
Robotic-assisted surgery for endometrial cancer: The need for further randomized trials. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-03 Elina Kivekäs,Synnöve Staff,Minna M Mäenpää
-
Reassessing robot-assisted laparoscopic surgery in endometrial cancer: Generalizability and key confounding factors. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-03 Ren Xu,Yanan Ren,Luyang Su
-
Primary vs interval cytoreductive surgery in stage IV ovarian cancer (SOFI-4). Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-03 Floriane Jochum,Cherif Akladios,
-
Reducing Preventable Maternal Deaths by Strengthening Mental Health Support: A Call for Action. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-03 Luyang Su,Zeqing Du
-
Investigation of Maternal Outcomes Following Respiratory Syncytial Virus Vaccination in the Third Trimester: Insights from a Real-World U.S. Electronic Health Records Database. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-05-03 Tina Yi Jin Hsieh,James Cheng-Chung Wei,Ai-Ris Collier
-
A comparison of the accuracy of different labor curves to predict labor progress. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-30 Emily F Hamilton,Philip A Warrick,John Parker,Roberto Romero
-
The Fetal Brain Neurosonography in Trisomy 21: the Seagull Sign and Thinned Subplate. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-29 Ritsuko K Pooh,Megumi Machida,Kohtaro Uenishi,Enoch Q S Barreto,Isabella Yi Man Wah,Liona C Poon,Kyoko Itoh,Takako Nakamura,Hideaki Chiyo,Hiroyasu Ohashi,Masayoshi Takeda,Osamu Shimokawa,Yoichi Matsubara
BACKGROUND Down syndrome, first systematically characterized by John Langdon Down in 1866 and later identified as trisomy 21 by Jérôme Lejeune in 1959, has seen dramatic improvements in life expectancy due to advances in medical care and social support. Despite this progress and the National Institutes of Health's INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE
-
MONITORING AND TIMING OF DELIVERY IN SUSPECTED LATE FETAL GROWTH RESTRICTION AT TERM Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-29 Piyanga Athauda, Zonglun Li, Ruth MacSwan, Roise Dudley, Jenny Stokes, Christina Ammari, Davide Casagrandi, Alexy Zaikin, Raffaele Napolitano
Babies affected by late fetal growth restriction are at risk of adverse perinatal outcomes, either due to placental insufficiency or the consequences of late iatrogenic prematurity. There is no randomized trial reporting the optimal timing of delivery and recommending delivery at 37 weeks can cause harm. Antenatal ultrasound parameters can be used to risk stratify late fetal growth restriction pregnancies
-
Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 2)—2025 update Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-28 R. Douglas Wilson MD MSc, David T. Monks MBChB, Nadir Sharawi MBBS, James Bamber MBChB, Danielle M. Panelli MD, Khara M. Sauro PhD, Prakeshkumar S. Shah MBBS, Giulia M. Muraca PhD, Amy Metcalfe PhD, Stephen L. Wood MD, Caitlin A. Jago MD, Sean Daly MD, Lindsay E.A. Blake EdD, George A. Macones MD, Aaron B. Caughey MD PhD, Pervez Sultan MBChB, Gregg Nelson MD PhD
Enhanced recovery after cesarean delivery protocols include evidence-based interventions which are designed to improve patient experience and maternal and neonatal outcomes, whilst reducing healthcare related costs. This is the first update to the Enhanced Recovery After Surgery Society guidelines for intraoperative care in cesarean delivery published in 2018. Interventions were selected based on expert
-
Guidelines for antenatal and preoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 1)—2025 update Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-28 R. Douglas Wilson MD MSc, David T. Monks MBChB, Nadir Sharawi MBBS, James Bamber MBChB, Danielle M. Panelli MD, Khara M. Sauro PhD, Prakeshkumar S. Shah MBBS, Giulia M. Muraca PhD, Amy Metcalfe PhD, Stephen L. Wood MD, Caitlin A. Jago MD, Sean Daly MD, Lindsay E.A. Blake EdD, George A. Macones MD, Aaron B. Caughey MD PhD, Pervez Sultan MBChB, Gregg Nelson MD PhD
Enhanced recovery after cesarean delivery protocols include evidence-based interventions designed to improve patient experience, pregnancy, and neonatal outcomes while reducing healthcare-related costs. This is the first update of the Enhanced Recovery After Surgery Society guidelines for antenatal and preoperative care before cesarean delivery after the original publication in 2018.
-
Guidelines for postoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 3)—2025 update Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-28 R. Douglas Wilson MD MSc, David T. Monks MBChB, Nadir Sharawi MBBS, James Bamber MBChB, Danielle M. Panelli MD, Khara M. Sauro PhD, Prakeshkumar S. Shah MBBS, Giulia M. Muraca PhD, Amy Metcalfe PhD, Stephen L. Wood MD, Caitlin A. Jago MD, Sean Daly MD, Lindsay E.A. Blake EdD, George A. Macones MD, Aaron B. Caughey MD PhD, Pervez Sultan MBChB, Gregg Nelson MD PhD
Enhanced Recovery After Cesarean Delivery (ERAC) protocols include evidence-based interventions designed to improve maternal and neonatal outcomes and patient experiences while reducing healthcare-related costs. This is the first update to the Enhanced Recovery After Surgery Society guidelines for postoperative care in cesarean delivery published in 2019. Interventions were selected based on expert
-
Comparative analysis of early vs late intravenous ferric carboxymaltose infusion for treatment of severe anemia Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-28 Christine Henricks DO, Rachel Schell MD, Jessica Pruszynski PhD, Catherine Y. Spong MD, Elaine Duryea MD
-
Provider insights to improve colposcopy adherence and feasibility of a social needs navigator program. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-24 Amanda J Compadre,Rachel Paul,Alexis Allihien,Rida Qureshi,Sarah Badwan,L Stewart Massad,Lindsay M Kuroki
-
Provider-Targeted Abortion Restrictions in the 2023 Legislative Session. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-24 Ruby M Aaron,Katelyn Downey,Maria I Rodriguez,Allison M Whelan,Jane M Zhu
-
Aspirin delays preeclampsia in women with chronic hypertension. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-24 Emmanuel Bujold,Daniel L Rolnik,Liona Poon,David Wright,Kypros H Nicolaides
-
Uptake and patient-related outcomes of mainstreaming genetic testing - a systematic review and meta-analysis. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-23 Ashwin Kalra,Subhasheenee Ganesan,Jacqueline Sia,Kyriaki-Barbara Papalois,Aayushi Pandya,Ran Xiong,Xia Wei,Samuel Oxley,Lea Mansour,Caitlin T Fierheller,Priyanka A Deshmukh,Hamda Mohamed,Amanda Dibden,Oleg Blyuss,Michail Sideris,Rosa Legood,Ranjit Manchanda
OBJECTIVE Mainstreaming genetic testing refers to genetic testing for cancer susceptibility genes following cancer diagnosis, which is provided by non-genetics health professionals of the cancer-treating team. Mainstreaming can be used to guide cancer treatment and secondary cancer prevention in the patient, and to identify carriers in the family members of patients who test positive through cascade
-
Optimizing delivery timing needs to be based on the risk stratification of placenta accreta spectrum Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-22 Yunshan Chen MD, Guochun Xiang MD, Yanming Jiang MD
-
Importance of risk stratification of placenta accreta spectrum: reply to Letter to the Editors. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-22 Alesha White,Catherine Y Spong,Christina L Herrera
-
Antenatal diagnosis of early-onset small-for-gestational age: absolute and relative risks of adverse outcomes. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-20 Jessica Liauw,Sanne J Gordijn,Wessel Ganzevoort,Chantal Mayer,Jennifer A Hutcheon
OBJECTIVE To determine the absolute and relative risks of adverse maternal, perinatal, and longer-term child outcomes for pregnancies with antenatally-detected early-onset small for gestational age fetuses, compared with baseline population rates. STUDY DESIGN We linked ultrasound data from pregnancies with antenatally-detected, non-anomalous, early-onset SGA fetuses (estimated fetal weight and/or
-
The risk for preeclampsia at 36 weeks and at 12 weeks predicts intrapartum fetal compromise and spontaneous onset of labor. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-20 Paolo I Cavoretto,Antonio Farina,Argyro Syngelaki,Filippos Solonos,Kypros H Nicolaides
-
Clarifying the clinical relevance of HPV detection transitions over time. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-19 Patti E Gravitt,Anne Hammer,
-
Ibuprofen in postpartum mothers with severe hypertensive disorders of pregnancy: a letter Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-19 Amiya Das MS DNB, Avir Sarkar MD DNB, Lisley Konar MS DNB, Prathamesh Lanjewar MBBS
-
Surgery for placenta accreta spectrum: randomized controlled study by whom? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Shigeki Matsubara MD PhD
-
Caution the role of ampicillin and gentamicin prophylaxis on clinical chorioamnionitis in patients with prelabor rupture of membranes at term Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Haiying Chen MM, Feng Qi MD
-
Practical applications of artificial intelligence chatbots in obstetrics and gynecology medical education Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Christopher M. Morosky MD MS, Laura Baecher-Lind MD MPH, Katherine T. Chen MD MPH, Angela Fleming DO, Shireen Madani Sims MD, Helen Kang Morgan MD, Celeste S. Royce MD, Tammy Sonn MD, Alyssa Stephenson-Famy MD, Jill Sutton MD, Jonathan Schaffir MD, Rashmi Bhargava MD FRCSC
Generative artificial intelligence chatbots are sophisticated conversational artificial intelligence tools that have the capability to interpret natural language inputs and produce responses that closely resemble human speech. Artificial intelligence chatbots hold significant promise in revolutionizing medical education by offering invaluable support across various educational domains, including teaching
-
Ibuprofen and hypertensive disorders of pregnancy: clinical considerations for our postpartum patient population Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Christina A. Penfield MD MPH, Megan C. Oakes MD MSCI, Jennifer A. Mcnulty MD
-
Managing clinical equipoise with placenta accreta–associated morbidity and prospective studies Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Jessian L. Munoz MD PhD MPH, Hendrik A. Lombaard MD, Amir A. Shamshirsaz MD
-
Reaffirming the clinical value of dual antibiotic prophylaxis in term prelabor rupture of membranes Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Raneen Abu Shqara MD, Hadas Shasha-Lavsky MD, Maya Frank Wolf MD
-
Are cesarean deliveries actually beneficial in singleton breech pregnancies under 32 weeks? Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Gabriel Lino, George Conrado MD MSc
-
Intrapartum electronic fetal monitoring and artificial intelligence: a worthwhile endeavor Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Jennifer A. McCoy MD MSCE, William G. La Cava PhD
-
Prevalence of male and female permanent contraception and long-acting reversible contraceptives among a commercially insured population in the United States, 2010 to 2022. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Hannah Thel,Chase D Latour,Danielle Tsevat,Mekhala V Dissanayake,Mollie E Wood,Kavita Shah Arora
-
Conservative management of placenta accreta spectrum disorder: a focus on future fertility Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Jessian L. Munoz MD PhD MPH, Amir A. Shamshirsaz MD, Hendrik A. Lombaard MD
-
Peer Influence on Physicians in Adopting Opportunistic Salpingectomy at the Time of Hysterectomy. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Xiao Xu,Jessica B Long,Craig Evan Pollack,Vrunda B Desai,Cary P Gross,Erica S Spatz,Jason D Wright
BACKGROUND Since professional societies recommended counseling patients about opportunistic salpingectomy (OS) for ovarian cancer risk reduction, use of OS has increased overall. However, physicians varied in their adoption of this new cancer prevention strategy. OBJECTIVES To examine peer influence among physicians as one possible factor affecting their adoption of OS at the time of hysterectomy.
-
Evaluating the Evidence: Cesarean Delivery and Neonatal Outcomes Before 33 Weeks of gestation. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Vivien Unger,Ákos Gasparics,Péter Varga
-
Importance of understanding latency in the natural history of human papillomavirus Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 José Eleutério Jr MD PhD, Marina Helena da Silva Lopes MSc
-
Bridging clinical evidence and societal impact: the role of conservative management in placenta accreta spectrum and fertility preservation Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Wei Cao MD
-
-
“Thin endometrium” at single-cell resolution Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Xiwen Zhang MB, Haining Lv MD PhD, Qiao Weng MD, Peipei Jiang MD PhD, Chenyan Dai MD, Guangfeng Zhao PhD, Yali Hu MD PhD
Thin endometrium is defined as an endometrial thickness of less than 7 mm in the midluteal phase of the menstrual cycle, a condition often seen in women of childbearing age with a history of uterine trauma, such as dilation and curettage or intrauterine adhesion separation. This inadequate thickness poses a substantial threat to endometrial receptivity and subsequent pregnancy, particularly during
-
The adult ovary at single cell resolution: an expert review Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Ilmatar Rooda PhD, Loren Méar PhD, Jasmin Hassan PhD, Pauliina Damdimopoulou PhD
The ovaries play a crucial role in both the endocrine health and fertility of adult women. The fundamental functional units of the ovaries, primordial follicles, form during fetal development and constitute the ovarian reserve. Ovaries age prematurely in comparison to other organs, with the quality of oocytes declining steeply prior to the entire reserve becoming depleted, usually around age 50. Despite
-
How to view the female reproductive tract through single-cell looking glasses Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Jaime Llera-Oyola MD, Raúl Pérez-Moraga MD, Marcos Parras PhD, Beatriz Rosón PhD
Single-cell technologies have emerged as an unprecedented tool for biologists and clinicians, allowing them to assess organs and tissues at the level of individual cells. In the field of women's reproductive biology, single-cell studies have provided insights into the cellular and molecular processes that regulate reproductive and obstetrical functions in health and disease. The knowledge that these
-
The maternal-fetal interface at single-cell resolution: uncovering the cellular anatomy of the placenta and decidua Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Dustyn Levenson BS, Roberto Romero MD, Derek Miller MS, Jose Galaz MD, Valeria Garcia-Flores PhD, Barbara Neshek MD, Roger Pique-Regi PhD, Nardhy Gomez-Lopez PhD
The maternal-fetal interface represents a critical site of immunological interactions that can greatly influence pregnancy outcomes. The unique cellular composition and cell-cell interactions taking place within these tissues has spurred substantial research efforts focused on the maternal-fetal interface. With the recent advent of single-cell technologies, multiple investigators have applied such
-
Uterine fibroids at single-cell resolution: unveiling cellular heterogeneity to improve understanding of pathogenesis and guide future therapies Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-18 Jyoti Goad PhD, Aleksandar Rajkovic MD PhD
Uterine leiomyomas or fibroids are benign tumors of the myometrium that affect approximately 70% of reproductive-age women. Fibroids continue to be the leading cause of hysterectomy, resulting in substantial healthcare costs. Genetic complexity and lack of cellular and molecular understanding of fibroids have posed considerable challenges to developing noninvasive treatment options. Over the years
-
Association between enlarged genital hiatus and prolapse with overactive bladder 1 year after vaginal delivery Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-16 Whitney K. Hendrickson MD, Amanda Allshouse MS, Ingrid E. Nygaard MD MS, Carolyn W. Swenson MD
Genital hiatus enlargement is associated with pelvic organ prolapse and overactive bladder 5 to 10 years after first delivery. It is unknown if this association is present earlier postpartum.
-
The association between serum soluble fms-like tyrosine kinase-1, placental growth factor, and soluble fms-like tyrosine kinase-1/placental growth factor ratio in singleton pregnancy and placental abruption: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-15 Katarzyna Kosińska-Kaczyńska,Iwona Szymusik,Robert Brawura Biskupski Samaha,Dorota Sys
OBJECTIVE The study aimed to evaluate whether women with singleton pregnancies who experienced subsequent placental abruption had lower serum placental growth factor concentrations, higher serum soluble fms-like tyrosine kinase-1 concentrations, and a higher soluble fms-like tyrosine kinase-1/placental growth factor ratio compared to women with singleton pregnancies without placental abruption. DATA
-
Perinatal use of nonalcoholic beverages that mirror alcohol Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-12 Molly A. Bowdring PhD, Meryl M. Sperling MD, Xi D. Plummer MD PhD, Judith J. Prochaska PhD MPH
-
The association of cytomegalovirus hyperimmune globulin with adverse pregnancy outcomes Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-11 Dwight J. Rouse MD, Cora MacPherson PhD, George R. Saade MD, Mara J. Dinsmoor MD MPH, Uma M. Reddy MD MPH, Robert Pass MD, Donna Allard RNC, Gail Mallett RN MS CCR, Rebecca G. Clifton PhD, Cynthia Gyamfi-Bannerman MD MS, Michael W. Varner MD, William H. Goodnight MD, Alan T.N. Tita MD PhD, Maged M. Costantine MD MBA, Geeta K. Swamy MD, Kent D. Heyborne MD, Edward K. Chien MD, Suneet P. Chauhan MD Hon
-
Wearable devices likely pose minimal biologic risk to female reproductive health Am. J. Obstet. Gynecol. (IF 8.7) Pub Date : 2025-04-10 Sarah C. Cromack MD, Jessica R. Walter MD MSCE